Innocoll stock slides 65% after FDA setback for pain treatment
December 30, 2016 at 11:10 AM EST
Analysts downgrade the stock on concerns the company could run out of money as it works to satisfy FDA requirements.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.